Download Citation
Article Source:
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults
Mpendo J,
Mutua G,
Nyombayire J,
Ingabire R,
Nanvubya A,
et al.
(2015)
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults.
PLOS ONE 10(8): e0134287.
https://doi.org/10.1371/journal.pone.0134287